# Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

> **NCT04928807** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 231 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **COMBINATION_PRODUCT:** Short course radiotherapy sequential camrelizumab and chemotherapy

## Key facts

- **NCT ID:** NCT04928807
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-20
- **Primary completion:** 2023-03-01
- **Final completion:** 2028-03-20
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04928807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04928807, "Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04928807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*